Your browser doesn't support javascript.
loading
Response assessment using [68 Ga]Ga-PSMA ligand PET in patients undergoing systemic therapy for metastatic castration-resistant prostate cancer.
Grubmüller, Bernhard; Rasul, Sazan; Baltzer, Pascal; Fajkovic, Harun; D'Andrea, David; Berndl, Florian; Maj-Hes, Agnes; Grubmüller, Karl Hermann; Mitterhauser, Markus; Wadsak, Wolfgang; Pfaff, Sarah; Shariat, Shahrokh F; Hacker, Marcus; Kramer, Gero; Hartenbach, Markus.
Afiliação
  • Grubmüller B; Department of Urology, Medical University of Vienna, Vienna, Austria.
  • Rasul S; Working Group of Diagnostic Imaging in Urology, Austrian Society of Urology, Vienna, Austria.
  • Baltzer P; Division of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.
  • Fajkovic H; Working Group of Diagnostic Imaging in Urology, Austrian Society of Urology, Vienna, Austria.
  • D'Andrea D; Division of General and Pediatric Radiology, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.
  • Berndl F; Department of Urology, Medical University of Vienna, Vienna, Austria.
  • Maj-Hes A; Working Group of Diagnostic Imaging in Urology, Austrian Society of Urology, Vienna, Austria.
  • Grubmüller KH; Department of Urology, Medical University of Vienna, Vienna, Austria.
  • Mitterhauser M; Department of Urology, Medical University of Vienna, Vienna, Austria.
  • Wadsak W; Department of Urology, Medical University of Vienna, Vienna, Austria.
  • Pfaff S; Department of Urology and Andrology, University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems, Austria.
  • Shariat SF; Division of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.
  • Hacker M; Ludwig Boltzmann Institute Applied Diagnostics, Vienna, Austria.
  • Kramer G; Division of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.
  • Hartenbach M; Center for biomarker research in medicine, CBmed GmbH, Graz, Austria.
Prostate ; 80(1): 74-82, 2020 01.
Article em En | MEDLINE | ID: mdl-31614001
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Oligopeptídeos / Ácido Edético / Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Male Idioma: En Revista: Prostate Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Áustria
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Oligopeptídeos / Ácido Edético / Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Male Idioma: En Revista: Prostate Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Áustria